腸溶性空カプセルの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

腸溶性空カプセルの市場動向

腸溶性空カプセルの世界市場規模は2023年に29億6,000万米ドルと推定され、2024年から2030年にかけてCAGR 6.54%で成長すると予測されています。市場の成長は、医薬品需要の増加、製薬会社による腸溶性カプセルの採用拡大、胃腸疾患の有病率の上昇、カプセル製造の技術進歩によってもたらされます。

製薬業界の成長は、腸溶性空カプセル市場の重要な促進要因です。世界人口の増加とヘルスケア意識の高まりにより、世界中で医薬品に対する需要が高まっています。2021年5月、エボニックは迅速かつ効果的な医薬品開発のための商業規模の機能性カプセル、EUDRACAPを発売しました。経口ドラッグデリバリー技術に基づくEUDRACAPは、生物学的製剤を含む感受性の高い分子を、開発の初期段階から商業規模にまで対応させる。

製薬会社は、胃の酸性環境での分解から薬剤を保護する能力から、腸溶性カプセルを選択する傾向が強まっています。Nutrientsの2024年3月の調査では、研究者らは、腸溶コーティング錠剤製剤が酸性条件下での炭酸水素ナトリウムの保護と腸内での放出を可能にすることを発見しました。このアプローチにより、血中重炭酸濃度が5mmol*L-1以上に達するのに必要な投与量が300mg*kg-1から225mg*kg-1に減少し、投与量が25％削減され、胃腸の不快感が軽減されます。

胃酸逆流、潰瘍、炎症性腸疾患などの胃腸疾患の有病率の増加は、腸溶性空カプセルの需要に拍車をかけています。これらの疾患を持つ患者は、胃をバイパスして腸で内容物を放出できる薬を必要とすることが多いです。2024年5月にMolecular Pharmaceutics誌に掲載された論文で、研究者らは回腸遠位部への正確なドラッグデリバリーのために設計された腸溶性コーティングカプセルを発表しました。

カプセル製造技術の進歩が市場の成長に寄与しています。コーティング技術や材料の改良などの技術革新により、性能と機能性が向上し、製薬メーカーにとってより魅力的なものとなっています。2021年5月、クオリカプス・欧州は、革新的なエクストラホワイトのビーガンオプションを含む25色以上のカラーオプションで、健康志向の消費者に対応する酸化チタンフリーのカプセルの新シリーズを発表しました。同社は120年以上にわたる専門知識により、成分マスキングのための高品質のカプセル化ソリューションを保証し、消費者向けヘルスケア製品を強化しています。

腸溶性空カプセルの世界市場セグメンテーションレポート

本レポートでは、世界、地域、国レベルでの収益成長を予測し、2018年から2030年までの各サブセグメントにおける最新の業界動向の分析を提供しています。この調査において、Grand View Research社は世界の腸溶性空カプセル市場レポートを製品、用途、最終用途、地域に基づいてセグメント化しています：

• 製品の展望（売上高、2018年～2030年）。
• ゼラチンカプセル。
• ヒドロキシプロピルメチルセルロース（HPMC）カプセル。
• 植物性カプセル。
• 用途の展望（売上高、2018年～2030年）。
• 制酸剤および整腸剤。
• 抗生物質および抗菌薬。
• その他。
• 最終用途の展望（売上、2018年～2030年）。
• 医薬品メーカー。
• 栄養補助食品メーカー。
• その他。
• 地域別展望（収入、2018年～2030年）。
• 北米。

米国。

カナダ

メキシコ

• 欧州

ドイツ

英国

フランス

イタリア

スペイン

デンマーク

スウェーデン

ノルウェー

• アジア太平洋

中国

日本

インド

韓国

オーストラリア

タイ

• ラテンアメリカ

ブラジル

アルゼンチン

• 中東・アフリカ

南アフリカ

サウジアラビア

UAE

クウェート

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腸溶性空カプセル市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 腸溶性空カプセル市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 腸溶性空カプセル市場：製品推定・動向分析

• セグメントダッシュボード
• 世界の腸溶性空カプセル市場の製品変動分析
• 世界の腸溶性空カプセル市場規模と動向分析、製品別、2018年～2030年
• ゼラチンカプセル
• ヒドロキシプロピルメチルセルロース（HPMC）カプセル
• 野菜カプセル

第5章 腸溶性空カプセル市場：用途推定・動向分析

• セグメントダッシュボード
• 世界の腸溶性空カプセル市場の用途変動分析
• 世界の腸溶性空カプセル市場規模と動向分析、用途別、2018年～2030年
• 制酸剤および整腸剤
• 抗生物質および抗菌薬
• その他

第6章 腸溶性空カプセル市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界の腸溶性空カプセル市場の最終用途変動分析
• 世界の腸溶性空カプセル市場規模と動向分析、最終用途別、2018年～2030年
• 製薬メーカー
• 栄養補助食品メーカー
• その他

第7章 腸溶性空カプセル市場：地域推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Lonza
  • Roquette Freres
  • SUHEUNG
  • Farmacapsulas
  • Nectar Lifesciences Ltd.
  • ZHEJIANG HUILI CAPSULES CO., LTD
  • Shaoxing Zhongya Capsule Co., Ltd.
  • Chemcaps Limited
  • Fortcaps
  • Natural Capsules Limited

List of Tables

• Table 1 List of abbreviations
• Table 2 Global enteric empty capsules market, by region, 2018 - 2030, (USD Million)
• Table 3 Global enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 4 Global enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 5 Global enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 6 North America enteric empty capsules market, by country, 2018 - 2030, (USD Million)
• Table 7 North America enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 8 North America enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 9 North America enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 10 U.S. enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 11 U.S. enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 12 U.S. enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 13 Canada enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 14 Canada enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 15 Canada enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 16 Mexico enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 17 Mexico enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 18 Mexico enteric empty capsules market, by end use, 2018 - 2030, (USD Million))
• Table 19 Europe enteric empty capsules market, by country, 2018 - 2030, (USD Million)
• Table 20 Europe enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 21 Europe enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 22 Europe enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 23 Germany enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 24 Germany enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 25 Germany enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 26 UK enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 27 UK enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 28 UK enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 29 France enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 30 France enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 31 France enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 32 Italy enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 33 Italy enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 34 Italy enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 35 Spain enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 36 Spain enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 37 Spain enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 38 Denmark enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 39 Denmark enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 40 Denmark enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 41 Sweden enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 42 Sweden enteric empty capsules market, by application, 2018 - 2030, (USD Million
• Table 43 Sweden enteric empty capsules market, by end use, 2018 - 2030, (USD Million
• Table 44 Norway enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 45 Norway enteric empty capsules market, by application, 2018 - 2030, (USD Million
• Table 46 Norway enteric empty capsules market, by end use, 2018 - 2030, (USD Million
• Table 47 Asia Pacific enteric empty capsules market, by country, 2018 - 2030, (USD Million)
• Table 48 Asia Pacific enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 49 Asia Pacific enteric empty capsules market, by application, 2018 - 2030, (USD Million
• Table 50 Asia Pacific enteric empty capsules market, by end use, 2018 - 2030, (USD Million
• Table 51 China enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 52 China enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 53 China enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 54 Japan enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 55 Japan enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 56 Japan enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 57 India enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 58 India enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 59 India enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 60 South Korea enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 61 South Korea enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 62 South Korea enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 63 Australia enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 64 Australia enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 65 Australia enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 66 Thailand enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 67 Thailand enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 68 Thailand enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 69 Latin America enteric empty capsules market, by country, 2018 - 2030, (USD Million)
• Table 70 Latin America enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 71 Latin America enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 72 Latin America enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 73 Brazil enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 74 Brazil enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 75 Brazil enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 76 Argentina enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 77 Argentina enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 78 Argentina enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 79 MEA enteric empty capsules market, by country, 2018 - 2030, (USD Million)
• Table 80 MEA enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 81 MEA enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 82 MEA enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 83 South Africa enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 84 South Africa enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 85 South Africa enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 86 Saudi Arabia enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 87 Saudi Arabia enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 88 Saudi Arabia enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 89 UAE enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 90 UAE enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 91 UAE enteric empty capsules market, by end use, 2018 - 2030, (USD Million)
• Table 92 Kuwait enteric empty capsules market, by product, 2018 - 2030, (USD Million)
• Table 93 Kuwait enteric empty capsules market, by application, 2018 - 2030, (USD Million)
• Table 94 Kuwait enteric empty capsules market, by end use, 2018 - 2030, (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Enteric empty capsules market: Market outlook
• Fig. 5 Enteric empty capsules market: Segment outlook
• Fig. 6 Enteric empty capsules market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Enteric empty capsules market driver impact
• Fig. 9 Enteric empty capsules market restraint impact
• Fig. 10 Enteric empty capsules market: Product outlook and key takeaways
• Fig. 11 Enteric empty capsules market: Product movement analysis
• Fig. 12 Gelatin capsules mattress market estimates and forecast, 2018 - 2030, (USD Million)
• Fig. 13 Hydroxypropyl ethylcellulose (HPMC) capsules market estimates and forecast, 2018 - 2030, (USD Million)
• Fig. 14 Vegetable capsules market estimates and forecast, 2018 - 2030, (USD Million)
• Fig. 15 Enteric empty capsules market: Application outlook and key takeaways
• Fig. 16 Enteric empty capsules market: Application movement analysis
• Fig. 17 Antacid and antiflatulent preparations market estimates and forecast, 2018 - 2030, (USD Million)
• Fig. 18 Antibiotic and antibacterial drugs market estimates and forecast, 2018 - 2030, (USD Million
• Fig. 19 Others market estimates and forecast, 2018 - 2030, (USD Million)
• Fig. 20 Enteric empty capsules market: End Use outlook and key takeaways
• Fig. 21 Enteric empty capsules market: End Use movement analysis
• Fig. 22 Pharmaceutical manufacturers market estimates and forecast, 2018 - 2030, (USD Million)
• Fig. 23 Nutraceutical manufacturers market estimates and forecast, 2018 - 2030, (USD Million
• Fig. 24 Other end use market estimates and forecast, 2018 - 2030, (USD Million)
• Fig. 25 Global enteric empty capsules market: Regional outlook and key takeaways
• Fig. 26 Global enteric empty capsules market: Regional movement analysis
• Fig. 27 North America market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 28 U.S. market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 29 Canada market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 30 Mexico market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 31 Europe market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 32 UK market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 33 Germany market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 34 France market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 35 Italy market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 36 Spain market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 37 Denmark market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 38 Sweden market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 39 Norway market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 41 China market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 42 Japan market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 43 India market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 44 Thailand market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 45 South Korea market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 46 Australia market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 47 Latin America market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 48 Brazil market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 49 Argentina market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 50 Middle East and Africa market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 51 South Africa market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 53 UAE market estimates and forecasts, 2018 - 2030, (USD Million)
• Fig. 54 Kuwait market estimates and forecasts, 2018 - 2030, (USD Million)

Enteric Empty Capsules Market Trends

The global enteric empty capsules market size was estimated at USD 2.96 billion in 2023 and is projected to grow at a CAGR of 6.54% from 2024 to 2030. The growth of the market is driven by an increasing demand for pharmaceutical products, growing adoption of enteric capsules by pharmaceutical companies, rising prevalence of gastrointestinal disorders, and technological advancements in capsule manufacturing.

The pharmaceutical industry's growth is a significant driver of the enteric empty capsules market. With the increasing global population and rising healthcare awareness, there is a growing demand for pharmaceutical products worldwide. They are widely used for encapsulating various drugs, especially those sensitive to gastric acid.In May 2021, Evonik launched EUDRACAP, a commercial-scale functional capsule for fast and effective drug development. EUDRACAP, based on oral drug delivery technology, accommodates sensitive molecules, including biologicals, from early development to commercial scaling.

Pharmaceutical companies are increasingly opting for enteric capsules due to their ability to protect drugs from degradation in the acidic environment of the stomach. This trend is driving the demand for enteric empty capsules in the market.In a March 2024 study from Nutrients, researchers found that an enteric-coated tablet formulation enables sodium bicarbonate protection in acidic conditions and its release in the intestine. This approach reduces the required dose to reach a blood bicarbonate level over 5 mmol*L-1 from 300 mg*kg-1 to 225 mg*kg-1, cutting the dose by 25% and lessening gastrointestinal discomfort.

The increasing prevalence of gastrointestinal disorders such as acid reflux, ulcers, and inflammatory bowel diseases is fueling the demand for enteric empty capsules. Patients with these conditions often require medications that can bypass the stomach and release their contents in the intestines. This has led to a higher utilization in drug delivery systems.In a May 2024 publication in Molecular Pharmaceutics, researchers presented enteric-coated capsules designed for precise drug delivery to the distal ileum, effectively targeting the area richest in Peyer's patches.

Advancements in capsule manufacturing technologies contribute to the market growth. Innovations such as improved coating techniques and materials have enhanced the performance and functionality, making them more appealing to pharmaceutical manufacturers. These technological advancements increase the efficiency and reliability in drug delivery applications.In May 2021, Qualicaps Europe introduced a new range of titanium dioxide-free capsules, catering to health-conscious consumers with over 25 color options, including an innovative extra-white vegan option. With more than 120 years of expertise, the company ensures high-quality encapsulation solutions for ingredient masking, enhancing consumer healthcare products.

Global Enteric Empty Capsules Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global enteric empty capsules market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Gelatin Capsules
• Hydroxypropyl Methylcellulose (HPMC) Capsules
• Vegetable Capsules
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Antacid and Antiflatulent Preparations
• Antibiotic and Antibacterial Drugs
• Others
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Pharmaceutical Manufacturers
• Nutraceutical Manufacturers
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

• Latin America

Brazil

Argentina

• MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Enteric Empty Capsules Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for pharmaceutical products
    • 3.2.1.2. Growing adoption of enteric capsules by pharmaceutical companies
    • 3.2.1.3. Rising prevalence of gastrointestinal disorders,
    • 3.2.1.4. Technological advancements in capsule manufacturing.
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Regulatory Challenges
• 3.3. Enteric Empty Capsules Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Enteric Empty Capsules Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Enteric Empty Capsules Market Product Movement Analysis
• 4.3. Global Enteric Empty Capsules Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Gelatin Capsules
  • 4.4.1. Gelatin capsules market estimates and forecasts 2018 to 2030, (USD Million)
• 4.5. Hydroxypropyl Methylcellulose (HPMC) Capsules
  • 4.5.1. Hydroxypropyl methylcellulose (HPMC) capsules market estimates and forecasts 2018 to 2030, (USD Million)
• 4.6. Vegetable Capsules
  • 4.6.1. Vegetable capsules market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 5. Enteric Empty Capsules Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Enteric Empty Capsules Market Application Movement Analysis
• 5.3. Global Enteric Empty Capsules Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Antacid and Antiflatulent Preparations
  • 5.4.1. Antacid and antiflatulent preparations market estimates and forecasts 2018 to 2030, (USD Million)
• 5.5. Antibiotic and Antibacterial Drugs
  • 5.5.1. Antibiotic and antibacterial drugs market estimates and forecasts 2018 to 2030, (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 6. Enteric Empty Capsules Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Enteric Empty Capsules Market End Use Movement Analysis
• 6.3. Global Enteric Empty Capsules Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical Manufacturers
  • 6.4.1. Pharmaceutical manufacturers market estimates and forecasts 2018 to 2030, (USD Million)
• 6.5. Nutraceutical Manufacturers
  • 6.5.1. Nutraceutical manufacturers market estimates and forecasts 2018 to 2030, (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Enteric Empty Capsules Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2023
• 8.4. Company Profiles/Listing
  • 8.4.1. Lonza
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Roquette Freres
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. SUHEUNG
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Farmacapsulas
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Nectar Lifesciences Ltd.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. ZHEJIANG HUILI CAPSULES CO., LTD
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Shaoxing Zhongya Capsule Co., Ltd.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Chemcaps Limited
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Fortcaps
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Natural Capsules Limited
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives